Monthly shot aims to slow MS progression
Disease control
Terminated
This study tested a long-acting form of glatiramer acetate (GA Depot) given as a monthly shot to people with primary progressive multiple sclerosis (PPMS). The goal was to see if it could safely slow down worsening disability. The study planned to enroll 30 adults aged 18-65 with…
Phase: PHASE2 • Sponsor: Mapi Pharma Ltd. • Aim: Disease control
Last updated May 08, 2026 12:02 UTC